ID   DCAM_HUMAN              Reviewed;         334 AA.
AC   P17707; E1P5F7; Q5VXN4; Q5VXN6; Q9BWK4;
DT   01-AUG-1990, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 2.
DT   12-APR-2017, entry version 184.
DE   RecName: Full=S-adenosylmethionine decarboxylase proenzyme;
DE            Short=AdoMetDC;
DE            Short=SAMDC;
DE            EC=4.1.1.50 {ECO:0000269|PubMed:10029540, ECO:0000269|PubMed:10574985, ECO:0000269|PubMed:11583147, ECO:0000269|PubMed:1917972, ECO:0000269|PubMed:2460457, ECO:0000269|PubMed:2687270};
DE   Contains:
DE     RecName: Full=S-adenosylmethionine decarboxylase alpha chain;
DE   Contains:
DE     RecName: Full=S-adenosylmethionine decarboxylase beta chain;
DE   Flags: Precursor;
GN   Name=AMD1; Synonyms=AMD;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PARTIAL PROTEIN SEQUENCE,
RP   CATALYTIC ACTIVITY, PROTEOLYTIC CLEAVAGE, AND PYRUVATE FORMATION AT
RP   SER-68.
RX   PubMed=2460457;
RA   Pajunen A., Crozat A., Jaenne O.A., Ihalainen R., Laitinen P.H.,
RA   Stanley B., Madhubala R., Pegg A.E.;
RT   "Structure and regulation of mammalian S-adenosylmethionine
RT   decarboxylase.";
RL   J. Biol. Chem. 263:17040-17049(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Heart;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   CATALYTIC ACTIVITY, PROTEOLYTIC CLEAVAGE, AND MUTAGENESIS OF SER-50;
RP   SER-66; SER-68 AND SER-69.
RX   PubMed=2687270;
RA   Stanley B.A., Pegg A.E., Holm I.;
RT   "Site of pyruvate formation and processing of mammalian S-
RT   adenosylmethionine decarboxylase proenzyme.";
RL   J. Biol. Chem. 264:21073-21079(1989).
RN   [7]
RP   MUTAGENESIS.
RX   PubMed=1917972;
RA   Stanley B.A., Pegg A.E.;
RT   "Amino acid residues necessary for putrescine stimulation of human S-
RT   adenosylmethionine decarboxylase proenzyme processing and catalytic
RT   activity.";
RL   J. Biol. Chem. 266:18502-18506(1991).
RN   [8]
RP   CATALYTIC ACTIVITY, PROTEOLYTIC CLEAVAGE, AND MUTAGENESIS OF SER-229
RP   AND HIS-243.
RX   PubMed=10574985; DOI=10.1074/jbc.274.49.35059;
RA   Xiong H., Pegg A.E.;
RT   "Mechanistic studies of the processing of human S-adenosylmethionine
RT   decarboxylase proenzyme. Isolation of an ester intermediate.";
RL   J. Biol. Chem. 274:35059-35066(1999).
RN   [9]
RP   CATALYTIC ACTIVITY, INHIBITION BY IODOACETIC ACID, AND MUTAGENESIS OF
RP   CYS-82.
RX   PubMed=10029540; DOI=10.1021/bi9825201;
RA   Xiong H., Stanley B.A., Pegg A.E.;
RT   "Role of cysteine-82 in the catalytic mechanism of human S-
RT   adenosylmethionine decarboxylase.";
RL   Biochemistry 38:2462-2470(1999).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-298, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.25 ANGSTROMS).
RX   PubMed=10378277; DOI=10.1016/S0969-2126(99)80074-4;
RA   Ekstrom J.L., Mathews I.I., Stanley B.A., Pegg A.E., Ealick S.E.;
RT   "The crystal structure of human S-adenosylmethionine decarboxylase at
RT   2.25-A resolution reveals a novel fold.";
RL   Structure 7:583-595(1999).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS), CATALYTIC ACTIVITY, REACTION
RP   MECHANISM, ACTIVE SITE, AND MUTAGENESIS OF PHE-7 AND PHE-223.
RX   PubMed=11583147; DOI=10.1021/bi010735w;
RA   Tolbert W.D., Ekstrom J.L., Mathews I.I., Secrist J.A. III, Kapoor P.,
RA   Pegg A.E., Ealick S.E.;
RT   "The structural basis for substrate specificity and inhibition of
RT   human S-adenosylmethionine decarboxylase.";
RL   Biochemistry 40:9484-9494(2001).
CC   -!- FUNCTION: Essential for biosynthesis of the polyamines spermidine
CC       and spermine. Promotes maintenance and self-renewal of embryonic
CC       stem cells, by maintaining spermine levels.
CC       {ECO:0000250|UniProtKB:P0DMN7}.
CC   -!- CATALYTIC ACTIVITY: S-adenosyl-L-methionine = S-adenosyl 3-
CC       (methylthio)propylamine + CO(2). {ECO:0000269|PubMed:10029540,
CC       ECO:0000269|PubMed:10574985, ECO:0000269|PubMed:11583147,
CC       ECO:0000269|PubMed:1917972, ECO:0000269|PubMed:2460457,
CC       ECO:0000269|PubMed:2687270}.
CC   -!- COFACTOR:
CC       Name=pyruvate; Xref=ChEBI:CHEBI:15361;
CC       Note=Binds 1 pyruvoyl group covalently per subunit.;
CC   -!- ENZYME REGULATION: Both proenzyme processing and catalytic
CC       activity are stimulated by putrescine. Catalytic activity is
CC       inhibited by iodoacetic acid.
CC   -!- PATHWAY: Amine and polyamine biosynthesis; S-
CC       adenosylmethioninamine biosynthesis; S-adenosylmethioninamine from
CC       S-adenosyl-L-methionine: step 1/1.
CC   -!- SUBUNIT: Heterotetramer of two alpha and two beta chains.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P17707-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P17707-2; Sequence=VSP_043209;
CC   -!- PTM: Is synthesized initially as an inactive proenzyme. Formation
CC       of the active enzyme involves a self-maturation process in which
CC       the active site pyruvoyl group is generated from an internal
CC       serine residue via an autocatalytic post-translational
CC       modification. Two non-identical subunits are generated from the
CC       proenzyme in this reaction, and the pyruvate is formed at the N-
CC       terminus of the alpha chain, which is derived from the carboxyl
CC       end of the proenzyme. The post-translation cleavage follows an
CC       unusual pathway, termed non-hydrolytic serinolysis, in which the
CC       side chain hydroxyl group of the serine supplies its oxygen atom
CC       to form the C-terminus of the beta chain, while the remainder of
CC       the serine residue undergoes an oxidative deamination to produce
CC       ammonia and the pyruvoyl group blocking the N-terminus of the
CC       alpha chain. {ECO:0000269|PubMed:10574985,
CC       ECO:0000269|PubMed:1917972, ECO:0000269|PubMed:2460457,
CC       ECO:0000269|PubMed:2687270}.
CC   -!- SIMILARITY: Belongs to the eukaryotic AdoMetDC family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M21154; AAA51716.1; -; mRNA.
DR   EMBL; AL832698; CAI46113.1; -; mRNA.
DR   EMBL; AL357515; CAH73388.1; -; Genomic_DNA.
DR   EMBL; AL365206; CAH73388.1; JOINED; Genomic_DNA.
DR   EMBL; AL365206; CAI23233.1; -; Genomic_DNA.
DR   EMBL; AL357515; CAI23233.1; JOINED; Genomic_DNA.
DR   EMBL; AL357515; CAH73390.1; -; Genomic_DNA.
DR   EMBL; AL365206; CAH73390.1; JOINED; Genomic_DNA.
DR   EMBL; AL365206; CAI23235.1; -; Genomic_DNA.
DR   EMBL; CH471051; EAW48307.1; -; Genomic_DNA.
DR   EMBL; CH471051; EAW48308.1; -; Genomic_DNA.
DR   EMBL; CH471051; EAW48309.1; -; Genomic_DNA.
DR   EMBL; BC000171; AAH00171.1; -; mRNA.
DR   CCDS; CCDS5086.1; -. [P17707-1]
DR   PIR; A31786; DCHUDM.
DR   RefSeq; NP_001625.2; NM_001634.5. [P17707-1]
DR   UniGene; Hs.159118; -.
DR   PDB; 1I72; X-ray; 2.00 A; A=68-334, B=1-67.
DR   PDB; 1I79; X-ray; 2.01 A; A=68-334, B=1-67.
DR   PDB; 1I7B; X-ray; 1.90 A; A=68-334, B=1-67.
DR   PDB; 1I7C; X-ray; 2.40 A; A=68-334, B=1-67.
DR   PDB; 1I7M; X-ray; 2.24 A; A/C=68-334, B/D=1-67.
DR   PDB; 1JEN; X-ray; 2.25 A; A/C=69-334, B/D=1-67.
DR   PDB; 1JL0; X-ray; 1.50 A; A/B=1-334.
DR   PDB; 1MSV; X-ray; 1.75 A; A/B=1-334.
DR   PDB; 3DZ2; X-ray; 1.86 A; A=69-334, B=1-67.
DR   PDB; 3DZ3; X-ray; 2.62 A; A=69-334, B=1-67.
DR   PDB; 3DZ4; X-ray; 1.84 A; A=69-334, B=1-67.
DR   PDB; 3DZ5; X-ray; 2.43 A; A=69-334, B=1-67.
DR   PDB; 3DZ6; X-ray; 1.83 A; A=69-334, B=1-67.
DR   PDB; 3DZ7; X-ray; 1.91 A; A=69-334, B=1-67.
DR   PDB; 3EP3; X-ray; 1.84 A; A=69-328, B=1-67.
DR   PDB; 3EP4; X-ray; 1.89 A; A=69-328, B=1-67.
DR   PDB; 3EP5; X-ray; 1.99 A; A=69-328, B=1-67.
DR   PDB; 3EP6; X-ray; 1.70 A; A=69-328, B=1-67.
DR   PDB; 3EP7; X-ray; 2.00 A; A=69-328, B=1-67.
DR   PDB; 3EP8; X-ray; 1.97 A; A=69-328, B=1-67.
DR   PDB; 3EP9; X-ray; 2.35 A; A=69-328, B=1-67.
DR   PDB; 3EPA; X-ray; 2.10 A; A=69-328, B=1-67.
DR   PDB; 3EPB; X-ray; 1.75 A; A=69-328, B=1-67.
DR   PDB; 3H0V; X-ray; 2.24 A; A=69-334, B=1-67.
DR   PDB; 3H0W; X-ray; 1.81 A; A=69-334, B=1-67.
DR   PDBsum; 1I72; -.
DR   PDBsum; 1I79; -.
DR   PDBsum; 1I7B; -.
DR   PDBsum; 1I7C; -.
DR   PDBsum; 1I7M; -.
DR   PDBsum; 1JEN; -.
DR   PDBsum; 1JL0; -.
DR   PDBsum; 1MSV; -.
DR   PDBsum; 3DZ2; -.
DR   PDBsum; 3DZ3; -.
DR   PDBsum; 3DZ4; -.
DR   PDBsum; 3DZ5; -.
DR   PDBsum; 3DZ6; -.
DR   PDBsum; 3DZ7; -.
DR   PDBsum; 3EP3; -.
DR   PDBsum; 3EP4; -.
DR   PDBsum; 3EP5; -.
DR   PDBsum; 3EP6; -.
DR   PDBsum; 3EP7; -.
DR   PDBsum; 3EP8; -.
DR   PDBsum; 3EP9; -.
DR   PDBsum; 3EPA; -.
DR   PDBsum; 3EPB; -.
DR   PDBsum; 3H0V; -.
DR   PDBsum; 3H0W; -.
DR   ProteinModelPortal; P17707; -.
DR   SMR; P17707; -.
DR   BioGrid; 106759; 30.
DR   DIP; DIP-363N; -.
DR   IntAct; P17707; 2.
DR   STRING; 9606.ENSP00000357880; -.
DR   BindingDB; P17707; -.
DR   ChEMBL; CHEMBL4181; -.
DR   DrugBank; DB08163; 5'-{[4-(aminooxy)butyl](methyl)amino}-5'-deoxy-8-ethenyladenosine.
DR   DrugBank; DB01917; Putrescine.
DR   DrugBank; DB00118; S-Adenosylmethionine.
DR   DrugBank; DB03754; Tris.
DR   iPTMnet; P17707; -.
DR   PhosphoSitePlus; P17707; -.
DR   DMDM; 116241324; -.
DR   EPD; P17707; -.
DR   MaxQB; P17707; -.
DR   PaxDb; P17707; -.
DR   PeptideAtlas; P17707; -.
DR   PRIDE; P17707; -.
DR   DNASU; 262; -.
DR   Ensembl; ENST00000368885; ENSP00000357880; ENSG00000123505. [P17707-1]
DR   GeneID; 262; -.
DR   KEGG; hsa:262; -.
DR   UCSC; uc003puk.3; human. [P17707-1]
DR   CTD; 262; -.
DR   DisGeNET; 262; -.
DR   GeneCards; AMD1; -.
DR   HGNC; HGNC:457; AMD1.
DR   HPA; HPA029281; -.
DR   HPA; HPA029282; -.
DR   MIM; 180980; gene.
DR   neXtProt; NX_P17707; -.
DR   OpenTargets; ENSG00000123505; -.
DR   PharmGKB; PA24763; -.
DR   eggNOG; KOG0788; Eukaryota.
DR   eggNOG; ENOG410XRN0; LUCA.
DR   GeneTree; ENSGT00390000011776; -.
DR   HOGENOM; HOG000159915; -.
DR   HOVERGEN; HBG000761; -.
DR   InParanoid; P17707; -.
DR   KO; K01611; -.
DR   OMA; ENFFYSR; -.
DR   OrthoDB; EOG091G1467; -.
DR   PhylomeDB; P17707; -.
DR   TreeFam; TF313561; -.
DR   BRENDA; 4.1.1.50; 2681.
DR   Reactome; R-HSA-351202; Metabolism of polyamines.
DR   SABIO-RK; P17707; -.
DR   UniPathway; UPA00331; UER00451.
DR   ChiTaRS; AMD1; human.
DR   EvolutionaryTrace; P17707; -.
DR   GenomeRNAi; 262; -.
DR   PMAP-CutDB; P17707; -.
DR   PRO; PR:P17707; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000123505; -.
DR   CleanEx; HS_AMD1; -.
DR   ExpressionAtlas; P17707; baseline and differential.
DR   Genevisible; P17707; HS.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0004014; F:adenosylmethionine decarboxylase activity; TAS:UniProtKB.
DR   GO; GO:0019810; F:putrescine binding; IBA:GO_Central.
DR   GO; GO:0006595; P:polyamine metabolic process; TAS:Reactome.
DR   GO; GO:0006557; P:S-adenosylmethioninamine biosynthetic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0046500; P:S-adenosylmethionine metabolic process; IEA:Ensembl.
DR   GO; GO:0008295; P:spermidine biosynthetic process; IBA:GO_Central.
DR   GO; GO:0006597; P:spermine biosynthetic process; IBA:GO_Central.
DR   Gene3D; 3.60.90.10; -; 1.
DR   InterPro; IPR001985; S-AdoMet_decarboxylase.
DR   InterPro; IPR016067; S-AdoMet_deCO2ase_core.
DR   InterPro; IPR018166; S-AdoMet_deCO2ase_CS.
DR   Pfam; PF01536; SAM_decarbox; 1.
DR   PIRSF; PIRSF001355; S-AdenosylMet_decarboxylase; 1.
DR   SUPFAM; SSF56276; SSF56276; 1.
DR   TIGRFAMs; TIGR00535; SAM_DCase; 1.
DR   PROSITE; PS01336; ADOMETDC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Autocatalytic cleavage;
KW   Complete proteome; Decarboxylase; Direct protein sequencing; Lyase;
KW   Phosphoprotein; Polyamine biosynthesis; Pyruvate; Reference proteome;
KW   S-adenosyl-L-methionine; Schiff base; Spermidine biosynthesis;
KW   Zymogen.
FT   CHAIN         1     67       S-adenosylmethionine decarboxylase beta
FT                                chain.
FT                                /FTId=PRO_0000029959.
FT   CHAIN        68    334       S-adenosylmethionine decarboxylase alpha
FT                                chain.
FT                                /FTId=PRO_0000029960.
FT   ACT_SITE      8      8       {ECO:0000269|PubMed:1917972}.
FT   ACT_SITE     11     11       {ECO:0000269|PubMed:1917972}.
FT   ACT_SITE     68     68       Schiff-base intermediate with substrate;
FT                                via pyruvic acid.
FT                                {ECO:0000269|PubMed:11583147}.
FT   ACT_SITE     82     82       Proton donor; for catalytic activity.
FT                                {ECO:0000269|PubMed:10029540,
FT                                ECO:0000269|PubMed:11583147}.
FT   ACT_SITE    229    229       Proton acceptor; for processing activity.
FT                                {ECO:0000269|PubMed:11583147}.
FT   ACT_SITE    243    243       Proton acceptor; for processing activity.
FT                                {ECO:0000269|PubMed:11583147}.
FT   BINDING       7      7       Substrate. {ECO:0000269|PubMed:11583147}.
FT   BINDING      67     67       Substrate. {ECO:0000269|PubMed:11583147}.
FT   BINDING     223    223       Substrate. {ECO:0000269|PubMed:11583147}.
FT   BINDING     247    247       Substrate. {ECO:0000269|PubMed:11583147}.
FT   SITE         67     68       Cleavage (non-hydrolytic); by autolysis.
FT                                {ECO:0000269|PubMed:2460457,
FT                                ECO:0000269|PubMed:2687270}.
FT   MOD_RES      68     68       Pyruvic acid (Ser); by autocatalysis.
FT                                {ECO:0000269|PubMed:2460457,
FT                                ECO:0000269|PubMed:2687270}.
FT   MOD_RES     298    298       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   VAR_SEQ       1    148       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_043209.
FT   MUTAGEN       7      7       F->A: No effect.
FT                                {ECO:0000269|PubMed:11583147}.
FT   MUTAGEN       8      8       E->Q: Loss of activity. Normal
FT                                putrescine-stimulated processing.
FT                                {ECO:0000269|PubMed:10029540,
FT                                ECO:0000269|PubMed:1917972}.
FT   MUTAGEN      11     11       E->Q: Loss of activity. Loss of
FT                                putrescine-stimulated processing.
FT                                {ECO:0000269|PubMed:1917972}.
FT   MUTAGEN      15     15       E->Q: Little effect.
FT                                {ECO:0000269|PubMed:1917972}.
FT   MUTAGEN      49     49       C->A: Little effect.
FT                                {ECO:0000269|PubMed:1917972}.
FT   MUTAGEN      50     50       S->A: 17 percent decrease in catalytic
FT                                activity. No effect on processing.
FT                                {ECO:0000269|PubMed:2687270}.
FT   MUTAGEN      61     61       E->Q: Little effect.
FT                                {ECO:0000269|PubMed:1917972}.
FT   MUTAGEN      66     66       S->A: 38 percent decrease in catalytic
FT                                activity. Slight reduction in processing.
FT                                {ECO:0000269|PubMed:2687270}.
FT   MUTAGEN      67     67       E->Q: Little effect.
FT                                {ECO:0000269|PubMed:1917972}.
FT   MUTAGEN      68     69       SS->II: Loss of catalytic activity and
FT                                processing. {ECO:0000269|PubMed:2687270}.
FT   MUTAGEN      68     68       S->A: Loss of catalytic activity and
FT                                processing. {ECO:0000269|PubMed:2687270}.
FT   MUTAGEN      69     69       S->A: 24 percent decrease in catalytic
FT                                activity. Slight reduction in processing.
FT                                {ECO:0000269|PubMed:2687270}.
FT   MUTAGEN      80     80       K->A: Greatly reduced catalytic activity.
FT                                No putrescine-stimulated processing.
FT                                {ECO:0000269|PubMed:1917972}.
FT   MUTAGEN      82     82       C->A: Loss of activity. Greatly reduced
FT                                putrescine-stimulated processing.
FT                                {ECO:0000269|PubMed:1917972}.
FT   MUTAGEN     223    223       F->A: No effect.
FT                                {ECO:0000269|PubMed:11583147}.
FT   MUTAGEN     226    226       C->A: Little effect.
FT                                {ECO:0000269|PubMed:1917972}.
FT   MUTAGEN     229    229       S->A: Loss of processing.
FT                                {ECO:0000269|PubMed:10574985}.
FT   MUTAGEN     229    229       S->C: Greatly reduced processing.
FT                                {ECO:0000269|PubMed:10574985}.
FT   MUTAGEN     229    229       S->T: Greatly reduced catalytic activity
FT                                but little effect on processing.
FT                                {ECO:0000269|PubMed:10574985}.
FT   MUTAGEN     243    243       H->A: Greatly reduced catalytic activity
FT                                and processing.
FT                                {ECO:0000269|PubMed:10574985}.
FT   MUTAGEN     243    243       H->E: Greatly reduced catalytic activity
FT                                and processing.
FT                                {ECO:0000269|PubMed:10574985}.
FT   MUTAGEN     243    243       H->F: Loss of processing.
FT                                {ECO:0000269|PubMed:10574985}.
FT   MUTAGEN     243    243       H->Y: Loss of processing.
FT                                {ECO:0000269|PubMed:10574985}.
FT   MUTAGEN     247    247       E->Q: Little effect.
FT                                {ECO:0000269|PubMed:1917972}.
FT   MUTAGEN     249    249       E->Q: Little effect.
FT                                {ECO:0000269|PubMed:1917972}.
FT   CONFLICT    146    146       A -> G (in Ref. 1; AAA51716).
FT                                {ECO:0000305}.
FT   STRAND       12     19       {ECO:0000244|PDB:1JL0}.
FT   HELIX        32     34       {ECO:0000244|PDB:1JL0}.
FT   HELIX        37     45       {ECO:0000244|PDB:1JL0}.
FT   TURN         46     48       {ECO:0000244|PDB:1JL0}.
FT   STRAND       51     56       {ECO:0000244|PDB:1JL0}.
FT   STRAND       58     65       {ECO:0000244|PDB:1JL0}.
FT   STRAND       68     81       {ECO:0000244|PDB:1JL0}.
FT   HELIX        87     90       {ECO:0000244|PDB:1JL0}.
FT   HELIX        91    102       {ECO:0000244|PDB:1JL0}.
FT   STRAND      106    115       {ECO:0000244|PDB:1JL0}.
FT   HELIX       120    122       {ECO:0000244|PDB:1JL0}.
FT   HELIX       130    138       {ECO:0000244|PDB:1JL0}.
FT   STRAND      142    150       {ECO:0000244|PDB:1JL0}.
FT   STRAND      157    162       {ECO:0000244|PDB:1JL0}.
FT   STRAND      175    183       {ECO:0000244|PDB:1JL0}.
FT   HELIX       186    189       {ECO:0000244|PDB:1JL0}.
FT   HELIX       190    192       {ECO:0000244|PDB:1JL0}.
FT   HELIX       200    206       {ECO:0000244|PDB:1JL0}.
FT   HELIX       209    211       {ECO:0000244|PDB:1JEN}.
FT   STRAND      212    215       {ECO:0000244|PDB:1JL0}.
FT   STRAND      217    222       {ECO:0000244|PDB:1JL0}.
FT   STRAND      224    226       {ECO:0000244|PDB:1JL0}.
FT   STRAND      228    233       {ECO:0000244|PDB:1JL0}.
FT   STRAND      239    245       {ECO:0000244|PDB:1JL0}.
FT   HELIX       248    250       {ECO:0000244|PDB:3H0W}.
FT   STRAND      252    257       {ECO:0000244|PDB:1JL0}.
FT   HELIX       265    275       {ECO:0000244|PDB:1JL0}.
FT   STRAND      278    287       {ECO:0000244|PDB:1JL0}.
FT   HELIX       291    296       {ECO:0000244|PDB:3EPB}.
FT   STRAND      305    314       {ECO:0000244|PDB:1JL0}.
FT   STRAND      316    327       {ECO:0000244|PDB:1JL0}.
SQ   SEQUENCE   334 AA;  38340 MW;  1BB433AF412C9179 CRC64;
     MEAAHFFEGT EKLLEVWFSR QQPDANQGSG DLRTIPRSEW DILLKDVQCS IISVTKTDKQ
     EAYVLSESSM FVSKRRFILK TCGTTLLLKA LVPLLKLARD YSGFDSIQSF FYSRKNFMKP
     SHQGYPHRNF QEEIEFLNAI FPNGAAYCMG RMNSDCWYLY TLDFPESRVI SQPDQTLEIL
     MSELDPAVMD QFYMKDGVTA KDVTRESGIR DLIPGSVIDA TMFNPCGYSM NGMKSDGTYW
     TIHITPEPEF SYVSFETNLS QTSYDDLIRK VVEVFKPGKF VTTLFVNQSS KCRTVLASPQ
     KIEGFKRLDC QSAMFNDYNF VFTSFAKKQQ QQQS
//
